Sabal Trust CO Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Sabal Trust CO boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 61,926 shares of the healthcare conglomerate’s stock after acquiring an additional 443 shares during the period. UnitedHealth Group makes up approximately 1.8% of Sabal Trust CO’s portfolio, making the stock its 15th largest position. Sabal Trust CO’s holdings in UnitedHealth Group were worth $31,326,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. AMF Tjanstepension AB raised its position in UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after purchasing an additional 121,180 shares during the period. Hudson Value Partners LLC grew its holdings in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the last quarter. Wealth Group Ltd. boosted its holdings in shares of UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares during the period. Howard Capital Management Group LLC acquired a new position in UnitedHealth Group in the third quarter valued at $341,000. Finally, GSG Advisors LLC raised its stake in UnitedHealth Group by 14.4% during the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock valued at $435,000 after acquiring an additional 94 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.9 %

Shares of UnitedHealth Group stock opened at $470.49 on Wednesday. The company has a market capitalization of $432.99 billion, a price-to-earnings ratio of 30.35, a P/E/G ratio of 1.37 and a beta of 0.61. The business has a fifty day simple moving average of $518.22 and a two-hundred day simple moving average of $559.08. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.79%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.